Neoadjuvant chemotherapy combined with immunotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Neoadjuvant chemotherapy combined with immunotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma

Published:2024-08 Issue:2 Volume:168 Page:417-428.e3
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Yu Yong-kui,Meng Fan-Yu,Wei Xiu-feng,Chen Xian-kai,Li Hao-miao,Liu Qi,Li Can-jun,Xie Hou-nai,Xu Lei,Zhang Rui-xiang,Xing Wenqun,Li Yin

Funder

Ministry of Science and Technology of the People's Republic of China

Publisher

Elsevier BV

Reference31 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

3. Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology;Ajani;J Natl Compr Canc Netw,2019

4. Neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil (PF) versus carboplatin and paclitaxel (CROSS regimen) for esophageal squamous cell carcinoma (ESCC): a propensity score-matched study;Wong;Ann Surg,2020

5. Recurrence patterns after neoadjuvant chemoradiotherapy compared with surgery alone in oesophageal squamous cell carcinoma: results from the multicenter phase III trial NEOCRTEC5010;Liu;Eur J Cancer,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, safety, and survival of neoadjuvant immunotherapy plus chemotherapy in locally advanced esophageal squamous cell carcinoma: A real-world retrospective study;International Immunopharmacology;2024-09

2. Commentary: Is neoadjuvant chemoimmunotherapy for esophageal cancer the next great frontier?;The Journal of Thoracic and Cardiovascular Surgery;2024-08

3. Is neoadjuvant chemotherapy combined with immunotherapy really better than neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma?;The Journal of Thoracic and Cardiovascular Surgery;2024-08

4. Long-term outcomes of smoker and drinker with oesophageal squamous cell carcinoma after oesophagectomy: a large-scale propensity score matching analysis;BMJ Open Gastroenterology;2024-08

5. Tumor immune microenvironment remodeling and prognosis of patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy with and without immunotherapy: a retrospective cohort study;Journal of Thoracic Disease;2024-06